Thyroid Disorder Therapy Market driven by Increase in thyroid cancer Cases | Global Industry Outlook 2019, Size Estimation, Share, Business Growth, Competitive Landscape and Regional Insights till 2026

Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism and hyperthyroidism. Thyroid can be caused by iodine deficiency and autoimmune disease. Iodine deficiency is a major factor that may lead to thyroid disorder. Technological advancement in thyroid disorder therapy is also driving growth of the thyroid disorder therapy market during the forecast period. Radioactive iodine (I-131) is been used to treat over-active thyroid disorders (hyperthyroidism). It is an effective method of treatment. It is now being used more often as a first-line treatment rather than surgery, which reduces the amount of thyroxin and size of gland.

Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/2687

Thyroid Disorder Therapy Market- Drivers

Thyroid cancer is one of the major problem which is increasing the demand for therapy. To meet the demand, many drugs are in a pipeline while few drugs received approvals. In May 2018, Food and Drug Administration (FDA) approved a combination of two targeted drugs, dabrafenib plus trametinib, to treat patients with anaplastic thyroid cancer. The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) is the first FDA approved treatment for these type of thyroid cancers. Moreover, in 2015, FDA approved Lenvatinib for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer. In the same year, Japan received the approval for manufacturing and marketing authorization in Japan for its Lenvima, an anticancer drug for the treatment of thyroid cancer.

Thyroid disorder therapy market size is also expected to witness significant growth over the forecast period, owing to increasing prevalence of thyroid cancer. For instance, according to National Cancer Institute of U.S report in 2016, there were an estimated 822,242 people living with thyroid cancer in the U.S. Furthermore, according to the American Cancer Society’s estimates for thyroid cancer in the U.S., around 52,070 new cases of thyroid cancer (14,260 in men and 37,810 in women) and around 2,170 deaths from thyroid cancer (1,020 men and 1,150 women)  in 2019.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/thyroid-disorder-therapy-market-2687

Thyroid Disorder Therapy Market-Restraints

High cost of thyroid disorder therapy may restrain growth of the thyroid disorder therapy market during the forecast period. For instance, according to National Center for Biotechnology Information 2015 report, the aggregate national cost of well-differentiated thyroid cancer (WDTC) care in 2013 was US$ 1.6 billion.

Thyroid Disorder Therapy Market-Regional Analysis

On the basis of region, the thyroid disorder therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the thyroid disorder therapy market during the forecast period, owing to increasing cases of thyroid condition. For instance, according to American Thyroid Association (ATA) 2019, over 12% of the U.S. population is expected to develop a thyroid condition during their lifetime.

Asia Pacific is the fastest growing market in the thyroid disorder therapy market due to increasing prevalence of thyroid disorder in the region. For instance, according to Indian Thyroid Society 2018, 42 million people in India have thyroid disorders such as hypothyroidism.

To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/2687

Thyroid Disorder Therapy Market- Competitive Landscape

Key players operating in the thyroid disorder therapy market include, Pfizer Inc., Merck & Co., Mylan N.V., Novartis A.G., Lanett company, Inc., Sanofi, AbbVie Inc., Aspen, GlaxoSmithKline, and Abbott laboratories.

Thyroid Disorder Therapy Market- Taxonomy

The thyroid disorder therapy market is segmented on the basis of disease type, drug class, application, route of administration, distribution channel, and region.

By Disease Type:

• Thyroid Cancer
• Hypothyroidism
• Hyperthyroidism
• Goiter

By Drug Class:

• Levothyroxine
• Liothyronine
• Kinase Inhibitors
• Anthracyclines
• Beta-Blockers

By Route of Administration: 

• Oral
• Intravenous

By Distribution Channel:

• Hospital Pharmacy
• Retail pharmacy
• Online Pharmacy

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Other Related Reports:

Thyroid Cancer Drugs Market, By Product Type (Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Cometriq (Cabozantinib-S-Malate), Lenvatinib Mesylate, Nivolumab, Vandetanib, and Others), By End Users (Hospitals, Oncology Clinics, Research Organizations, and Others), and By Region – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Liothyronine Market, by Product Type (Liothyronine Sodium, Combination Therapies, Others), by Indication (Hypothyroidism, Goiter, and Myxedema), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Clinics and Online Pharmacies), and by Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.